Extramedullary plasmacytoma continued to progress rapidly, possibly due to the suppression of the T-cell response by reducing CD8+ T-cell infiltration in the tumor microenvironment through binding with Th17-associated proinflammatory cytokines. This evidence concerns the gene CD8A and neoplasm.